EW-7197

  Cat. No.:  DC8342   Featured
Chemical Structure
1352608-82-2
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
EW-7197 is a potent ALK5 inhibitor. EW-7197 showed potent in vivo anti-metastatic activity, indicating its potential for use as an anti-cancer therapy.
Cas No.: 1352608-82-2
Chemical Name: Vactosertib
Synonyms: EW 7197;1H-​Imidazole-​2-​methanamine, N-​(2-​fluorophenyl)​-​5-​(6-​methyl-​2-​pyridinyl)​-​4-​[1,​2,​4]​triazolo[1,​5-​a]​pyridin-​6-​yl-;EW-7197;N-(2-Fluorophenyl)-5-(6-methyl-2-pyridinyl)-4-[1,2,4]triazolo-[1,5-a]pyridin-6-yl-1H-imidazole-2-methanamine;Vactosertib;TEW-7197;N-(2-Fluorophenyl)-5-(6-methyl-2-pyridinyl)-4-[1,2,4]triazolo[1,5-a]pyridin-6-yl-1H-imidazole-2-methanamine;N-[[4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]methyl]-2-fluoroaniline;GTPL8107;C22H18FN7;6T4O391P5Y;EX-A1
SMILES: FC1=C([H])C([H])=C([H])C([H])=C1N([H])C([H])([H])C1=NC(C2C([H])=C([H])C3=NC([H])=NN3C=2[H])=C(C2=C([H])C([H])=C([H])C(C([H])([H])[H])=N2)N1[H]
Formula: C22H18FN7
M.Wt: 399.4236
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Description: Vactosertib (EW-7197) is an ATP-competitive inhibitor of ALK5 with an IC50 of 12.9 nM. It also inhibits ALK2 and ALK4 at nanomolar concentrations.
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
2018-0101
Cat. No. Product name Field of application
DC6306 LY2157299(Galunisertib) LY2157299 is a potent TGFβ receptor I (TβRI) inhibitor with IC50 of 56 nM. Phase 2.
DC8342 EW-7197 EW-7197 is a potent ALK5 inhibitor. EW-7197 showed potent in vivo anti-metastatic activity, indicating its potential for use as an anti-cancer therapy.
X